Cargando…
Effect of narrowband ultraviolet B therapy on serum levels of CD26/dipeptidyl-peptidase IV and truncated forms of substance P in psoriasis patients with pruritus
PURPOSE: While pruritus affects approximately 60–90% of psoriasis patients, the pathogenesis of the condition remains unclear. CD26/dipeptidyl-peptidase IV (CD26/DPPIV) and truncated forms of substance P (SP) have been reported to play an important role in the pathogenesis of psoriatic itch. The aim...
Autores principales: | Kongthong, S, Phumyen, A, Meephansan, J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6711722/ https://www.ncbi.nlm.nih.gov/pubmed/31692558 http://dx.doi.org/10.2147/CCID.S216422 |
Ejemplares similares
-
CD26/Dipeptidyl Peptidase IV and Its Multiple Biological Functions
por: Pan, Kelsey, et al.
Publicado: (2021) -
Skin Microbiota Profiles from Tape Stripping and Skin Biopsy Samples of Patients with Psoriasis Treated with Narrowband Ultraviolet B
por: Rungjang, Atiya, et al.
Publicado: (2022) -
Management of Persistent Pruritus and Lichenoid Reaction Secondary to Nivolumab With Narrowband Ultraviolet B Phototherapy
por: Donaldson, Marie, et al.
Publicado: (2018) -
Regulation of Chemokine Activity – A Focus on the Role of Dipeptidyl Peptidase IV/CD26
por: Metzemaekers, Mieke, et al.
Publicado: (2016) -
Tackling dipeptidyl peptidase IV in neurological disorders
por: Al-Badri, Ghaith, et al.
Publicado: (2018)